catalase and glutathione supplements Frontiers Exploring Therapeutic Potential of Catalase:

doi: 10.1016/S0140-6736(18)30726-8

Understanding both helps explain why the type of food matters not just whether food was consumed at all

mechanistic and exploratory, not a clinical efficacy trial

Why isnt BPC-157 FDA-approved

A 2017 study by Hsieh and colleagues in Journal of Molecular Medicine reported that BPC-157, in chick chorioallantoic membrane, rat hind-limb ischemia, and HUVEC models, directionally increased vessel density, accelerated blood-flow recovery in ischemic muscle, and time-dependently activated the VEGFR2-Akt-eNOS signaling pathway via VEGFR2 internalization a mechanistic preclinical finding for which numeric effect sizes are not reported in the abstract